nrHSC
Pipeline
Developing Products
That Are Potent, Enabling,
Novel and Safe
That Are Potent, Enabling,
Novel and Safe
-
Product
Indication
Drug
DiscoveryPre-clinical
IND
Phase I
Phase II
Phase III
BLA
Commer-cialization
-
MVR-Vac11
MVR-Gen11
Vaccine
Gene Delivery
Technology Edge
Synergistic multi-protein engineering
Targeted delivery
Streamlined Drug Discovery
